Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuelle A D Schindler

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Current Topics in Behavioral Neurosciences|May 13, 2022
Psychedelics in the Treatment of Headache and Chronic Pain DisordersEmmanuelle A D Schindler
Neuropharmacology|June 19, 2022
Psychedelics as preventive treatment in headache and chronic pain disordersEmmanuelle A D Schindler
CNS Drugs|July 22, 2024
Psychotropic Drugs Reemerging as Headache MedicinesEmmanuelle A D Schindler
Current Pain and Headache Reports|August 4, 2023
The Potential of Psychedelics for the Treatment of Episodic MigraineEmmanuelle A D Schindler
BMJ (Clinical Research Ed.)|March 17, 2022
Recent advances in the diagnosis and management of cluster headacheEmmanuelle A D Schindler, Mark J Burish
Science (New York, N.Y.)|December 8, 2022
The therapeutic potential of psychedelicsEmmanuelle A D Schindler, Deepak Cyril D'Souza
Expert Review of Neurotherapeutics|August 31, 2023
Adapting psychedelic medicine for headache and chronic pain disordersEmmanuelle A D Schindler, Peter S Hendricks
Frontiers in Neurology|July 17, 2023
Case report: Psychedelic-induced seizures captured by intracranial electrocorticographyBenjamin N Blond, Emmanuelle A D Schindler
Current Neurology and Neuroscience Reports|July 17, 2024
Managing Cluster Headache in Patients with Medical, Psychiatric, and Surgical ComorbiditiesMark J Burish, Alexander B Guirguis, Emmanuelle A D Schindler
Brain Research|November 6, 2012
Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortexEmmanuelle A D Schindler, John A Harvey, Vincent J Aloyo
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Current Topics in Behavioral Neurosciences|May 13, 2022
Psychedelics in the Treatment of Headache and Chronic Pain DisordersEmmanuelle A D Schindler
Neuropharmacology|June 19, 2022
Psychedelics as preventive treatment in headache and chronic pain disordersEmmanuelle A D Schindler
CNS Drugs|July 22, 2024
Psychotropic Drugs Reemerging as Headache MedicinesEmmanuelle A D Schindler
Current Pain and Headache Reports|August 4, 2023
The Potential of Psychedelics for the Treatment of Episodic MigraineEmmanuelle A D Schindler
BMJ (Clinical Research Ed.)|March 17, 2022
Recent advances in the diagnosis and management of cluster headacheEmmanuelle A D Schindler, Mark J Burish
Science (New York, N.Y.)|December 8, 2022
The therapeutic potential of psychedelicsEmmanuelle A D Schindler, Deepak Cyril D'Souza
Expert Review of Neurotherapeutics|August 31, 2023
Adapting psychedelic medicine for headache and chronic pain disordersEmmanuelle A D Schindler, Peter S Hendricks
Frontiers in Neurology|July 17, 2023
Case report: Psychedelic-induced seizures captured by intracranial electrocorticographyBenjamin N Blond, Emmanuelle A D Schindler
Current Neurology and Neuroscience Reports|July 17, 2024
Managing Cluster Headache in Patients with Medical, Psychiatric, and Surgical ComorbiditiesMark J Burish, Alexander B Guirguis, Emmanuelle A D Schindler
Brain Research|November 6, 2012
Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortexEmmanuelle A D Schindler, John A Harvey, Vincent J Aloyo
Pageof 3